SCHEMBL5193365

SCHEMBL5193365

CCC(CC)n1cnc2c(Nc3ccc(C(=O)O)cc3)nc(Cl)nc21

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 10/20 0.78
CDK5R1 Q15078 10/20 0.78
NPC1 O15118 1/20 0.78
POLB P06746 1/20 0.78
CCNA2 P20248 10/20 0.54
CDK2 P24941 10/20 0.54
CCNA1 P78396 9/20 0.54
DYRK1A Q13627 6/20 0.54
YTHDC1 Q96MU7 3/20 0.53
HDAC1 Q13547 3/20 0.46
HDAC2 Q92769 3/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5193842 0.91 CDK5 (0.80) CDK5CDK5R1NPC1POLBCCNA2
SCHEMBL23494096 0.88 CDK5 (1.00) CDK5CDK5R1NPC1POLBCCNA2
SCHEMBL31307877 0.88 CDK5 (1.00) CDK5CDK5R1NPC1POLBCCNA2
SCHEMBL5630231 0.88 CDK5 (0.61) CDK5CDK5R1NPC1POLBCCNA2
SCHEMBL5193482 0.87 CDK5 (0.60) CDK5CDK5R1NPC1POLBCCNA2
SCHEMBL5193377 0.79 CDK5 (0.52) CDK5CDK5R1NPC1POLBCCNA2
SCHEMBL5626927 0.79 CDK5 (0.63) CDK5CDK5R1NPC1POLBCCNA2
SCHEMBL5194082 0.79 FLT3 (0.63) CCNA2CDK2CCNA1CDK1CCNE2
SCHEMBL5194072 0.79 FLT3 (0.63) CCNA2CDK2CCNA1CDK1CCNE2
SCHEMBL5193529 0.77 CDK5 (0.62) CDK5CDK5R1NPC1POLBCCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183256-B1 PURINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA SA (FR) 2007-08-22 EP disclosed
EP-1183256-A1 PURINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Aventis Pharma S.A. (FR) 2002-03-06 EP disclosed
WO-2000071543-A1 PURINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA S.A. (FR) 2000-11-30 WO disclosed